Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr;57(4):678-680.
doi: 10.1038/s41409-022-01600-1. Epub 2022 Feb 5.

Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience

Simona Piemontese  1 , Lorenzo Lazzari  2 , Annalisa Ruggeri  2 , Magda Marcatti  2 , Maria Teresa Lupo Stanghellini  2 , Fabio Giglio  2 , Raffaella Greco  2 , Francesca Lorentino  2 , Daniela Clerici  2 , Andrea Assanelli  2 , Francesca Farina  2 , Sara Mastaglio  2 , Elisabetta Xue  2 , Sarah Marktel  2 , Luca Vago  2   3 , Bernhard Gentner  2   3 , Chiara Secco  2 , Consuelo Corti  2 , Matteo Giovanni Carrabba  2 , Massimo Bernardi  2 , Jacopo Peccatori  2 , Fabio Ciceri  4   5
Affiliations

Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience

Simona Piemontese et al. Bone Marrow Transplant. 2022 Apr.
No abstract available

PubMed Disclaimer

References

    1. Klepin HD, Rao AV, Pardee TS. Acute myeloid leukemia and myelodysplastic syndromes in older adults. J Clin Oncol. 2014;32:2541–52. - DOI
    1. Danylesko I, Shimoni A, Nagler A. Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike. Bone Marrow Transplant. 2012;47:5–14. - DOI
    1. Michallet M, Sobh M, Milpied N, Bay J-O, Fürst S, Harousseau J-L, et al. Phase II prospective study of treosulfan-based reduced-intensity conditioning in allogeneic HSCT for hematological malignancies from 10/10 HLA-identical unrelated donor. Ann Hematol. 2012;91:1289–97. - DOI
    1. Shimoni A, Labopin M, Savani B, Hamladji R-M, Beelen D, Mufti G, et al. Intravenous busulfan compared with treosulfan-based conditioning for allogeneic stem cell transplantation in acute myeloid leukemia: a study on behalf of the acute leukemia working party of European Society for blood and marrow transplantation. Biol Blood Marrow Transpl. 2018;24:751–7. - DOI
    1. Beelen DW, Iacobelli S, Koster L, Eikema D-J, van Biezen A, Stoelzeet F, et al. Comparison of a New reduced toxicity myeloablative treosulfan and fludarabine preparative regimen with myeloablative busulfan or melphalan in combination with fludarabine in older patients with acute myeloid leukemia or myelodysplastic syndromes: a retrospective matched pair analysis of patients from a prospective randomized trial and the European Blood and Marrow Transplantation Society Registry. Blood. 2019;134:3326. - DOI

MeSH terms

LinkOut - more resources